SEC Form 4 · accession 0001213900-19-004013
IMMUCELL CORP /DE/ · ICCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul R Wainman
Director
Period of report
Mar 11, 2019
Accepted (ET)
Mar 13, 2019 · 9:10 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811641
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.10 per share | Mar 11, 2019 | A | 4,269 | $4.80 | A | 6,269 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Options (Right to buy) | $4.80 | Mar 11, 2019 | D | 10,731 | D | Mar 31, 2017 | Mar 31, 2019 | Common Stock | 10,731 | 0 | D |